InSilicoTrials Technologies
PrivateLast Round
Grant
Jan 28, 2021
Total Funding Raised
$5.71M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
InSilicoTrials Technologies operates in Healthcare & Life Sciences and is based in Trieste. Its latest recorded funding round was a Grant round in January 2021.
InSilicoTrials Technologies is a health tech company that provides a cloud-based platform with AI and simulation to predict drug and medical device safety and efficacy for pharmaceutical and biotech organizations.
Sector
Healthcare & Life Sciences
Verticals
Clinical Trials, Drug Discovery, Medical AI, Medical Devices
Business Model
B2B
Customer Profile
Usage-Based SaaS, Services & Consulting, Subscription SaaS, Government Contracts
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
InSilicoTrials Technologies Comparables
Compare InSilicoTrials Technologies with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| QuantHealth | 86% | |
| Nova In Silico | 83% | |
| Unlearn | 79% |
For institutional investors. Book with your work email.
InSilicoTrials Technologies Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Grant | Jan 28, 2021 | ||||
| Series A | Jul 27, 2020 |
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
InSilicoTrials Technologies Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| European Union's Horizon Research and Innovation program | Grant |
| Pi Campus | Series A |
| United Ventures | Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Aug 21, 2026
Monthly visitors grew 69% MoM, from 4.3K to 7.3K.
- Jan 21, 2026
Monthly visitors increased 54% MoM, reaching 5.4K.
For institutional investors. Book with your work email.
InSilicoTrials Technologies Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about InSilicoTrials Technologies's valuation, stock price, and market status.
Is InSilicoTrials Technologies a public or private company?
InSilicoTrials Technologies is a private company.
What is the current stock price of InSilicoTrials Technologies?
InSilicoTrials Technologies is a private company, so its shares have no public market price. Caplight tracks InSilicoTrials Technologies's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is InSilicoTrials Technologies worth (valuation)?
Valuation information for InSilicoTrials Technologies is not publicly available.
Can I buy InSilicoTrials Technologies stock?
InSilicoTrials Technologies shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was InSilicoTrials Technologies's last funding round?
InSilicoTrials Technologies's most recent funding round was Grant on January 28, 2021.
Who are the main investors in InSilicoTrials Technologies?
Key investors in InSilicoTrials Technologies include United Ventures.
Will InSilicoTrials Technologies IPO soon?
No public IPO plans have been announced for InSilicoTrials Technologies.
How can I track InSilicoTrials Technologies secondary market activity?
Caplight tracks bids, offers, and trades in InSilicoTrials Technologies's shares on secondary markets.